THE MINDMED VS. ATAI discussion you need to hear!
Prior to atai's IPO on the NASDAQ stock exchange, we repeatedly said that when atai Life Sciences goes public, the company will become MindMed ‘s ( MNMD: NASDAQ) (MMED: NEO) top competitor.
Well, atai did IPO on June 18 under ticker symbol “atai”. For this reason, I invited Jason Najum from Microdose.buzz to have a conversation. In this episode, we have a general discussion about:
– MindMed's flagship programs and the different businesses and programs ran under atai's umbrella.
– The companies' financial capability to run clinical trials.
-MindMed's and atai's potential to disrupt the way we treat mental illness within the next 5 to 10 years.
– Potential return on investment for retail investors.
0:00 – Intro
4:11 – What is atai's mission?
6:24 – What is MindMed's Mission
8:29 – atai's clinical trial pipeline
19:45 – MindMed's clinical trial pipeline
24:25 – How do MindMed and atai differ in business structure?
30:40 – Comparing the financials
Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
Enjoy the episode!
Check out Jason's writing at:
Follow us on social media! 🙌
Want to collaborate? Send us an email at:
Video editing: @themyaholy
Check out our Benziga discounts
DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.
All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change.
#MindMed #MNMD #Atai
Have you heard about our new community?
We’re excited to announce Bonfire -
a personal growth community for people who are interested in psychedelics.
Join us for our launch event on July 18th, where we’ll share about the work we’ll be doing together to actualize our personal missions, grow, and heal together.
Psychedelic Spotlight is your reliable source for the latest stories in the emerging psychedelics industry, covering breakthrough discoveries, investor news and cultural reform.